Chemomab Therapeutics Ltd - ADR
CMMB - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.11M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $8.11 Million |
|---|---|
| Enterprise Value | $2.11 Million |
| Earnings per Share | $-1.42 |
| Beta | 0.66 |
| Outstanding Shares | 8,003,049 |
Return
| Return on Equity | -87.47% |
|---|---|
| Return on Assets | -74.21% |
| Return on Invested Capital | -91.86% |
Valuation & Multiples
| P/E Ratio | -1.14 |
|---|---|
| PEG | -16.08 |
| Price to Sales | - |
| Price to Book Ratio | 1.18 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.26 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-0.15
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
$-0.01
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.13%▼ 3.62% |
|---|---|
| Total Invested | $107,339▼ 82.56% |
| Investors Holding | 3▼ 10.00% |
About Chemomab Therapeutics Ltd
2,020 employees
Chemomab is a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need. Based on the unique and pivotal role of the soluble protein CCL24 in pr...